
Medpace Holdings MEDP
€ 388.74
1.06%
Quartalsbericht 2026-Q1
hinzugefügt 23.04.2026
Medpace Holdings EV/EBITDA 2011-2026 | MEDP
EV/EBITDA Jährlich Medpace Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 30.7 | 23.9 | 20.1 | 16.6 | 14.9 | 12.2 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 30.7 | 12.2 | 19.8 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-134 | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
-8.71 | $ 18.63 | 2.14 % | $ 573 M | ||
|
Guardant Health
GH
|
-38.2 | $ 129.9 | -2.49 % | $ 16.3 B | ||
|
ICON Public Limited Company
ICLR
|
20 | $ 137.46 | 0.48 % | $ 10.8 B | ||
|
Agilent Technologies
A
|
27.4 | $ 137.03 | 1.22 % | $ 41.7 B | ||
|
Interpace Biosciences
IDXG
|
3.62 | $ 1.8 | - | $ 7.96 M | ||
|
Celcuity
CELC
|
-32.4 | $ 133.18 | 1.73 % | $ 6.23 B | ||
|
Akumin
AKU
|
23.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
0.0391 | $ 8.74 | -21.94 % | $ 11.6 M | ||
|
Castle Biosciences
CSTL
|
-227 | $ 21.28 | -3.75 % | $ 617 M | ||
|
Aspira Women's Health
AWH
|
-1.36 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.05 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 22.93 | 1.01 % | $ 1.22 B | ||
|
Chembio Diagnostics
CEMI
|
-1.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.000843 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.156 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
70.5 | $ 164.99 | 3.96 % | $ 26.2 B | ||
|
Lantheus Holdings
LNTH
|
15.5 | $ 100.23 | 0.61 % | $ 6.76 B | ||
|
Global Cord Blood Corporation
CO
|
-4.15 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Mettler-Toledo International
MTD
|
627 | $ 1 180.51 | 1.33 % | $ 24.3 B | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 10.64 | 4.42 % | $ 1.36 B | ||
|
National Research Corporation
NRC
|
14.3 | $ 20.1 | 2.24 % | $ 450 M | ||
|
Natera
NTRA
|
-19.5 | $ 221.69 | 3.62 % | $ 21.8 B | ||
|
Charles River Laboratories International
CRL
|
26.6 | $ 183.79 | 1.35 % | $ 9.11 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
-1.79 | $ 4.04 | -4.38 % | $ 374 M | ||
|
Personalis
PSNL
|
-4.87 | $ 11.73 | 6.83 % | $ 1.05 B | ||
|
Koninklijke Philips N.V.
PHG
|
17.1 | $ 26.59 | 0.53 % | $ 25.2 B | ||
|
Senseonics Holdings
SENS
|
-5.62 | $ 6.73 | 0.07 % | $ 281 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
186 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.38 | -2.26 % | $ 5.47 M | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 70.6 | 2.28 % | $ 4.22 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 262.1 | 0.02 % | $ 21.8 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 496.24 | 1.85 % | $ 187 B | ||
|
Trinity Biotech plc
TRIB
|
-15.5 | $ 0.71 | 1.49 % | $ 255 M | ||
|
Motus GI Holdings
MOTS
|
-0.0496 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.21 | -0.97 % | $ 2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 195.43 | -0.39 % | $ 21.7 B | ||
|
Invitae Corporation
NVTA
|
44.6 | - | - | $ 21.2 M |